Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Priorities in future research in prostate cancer screening.

× No keyword cloud information.

22 in total

1. International trends in prostate-cancer mortality in the "PSA ERA".

Authors: S E Oliver; M T May; D Gunnell
Journal: Int J Cancer Date: 2001-06-15 Impact factor: 7.396

2. Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland.

Authors: M Hakama; U H Stenman; A Aromaa; J Leinonen; T Hakulinen; P Knekt
Journal: J Urol Date: 2001-12 Impact factor: 7.450

3. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.

Authors: René Raaijmakers; Wim J Kirkels; Monique J Roobol; Mark F Wildhagen; Fritz H Schrder
Journal: Urology Date: 2002-11 Impact factor: 2.649

4. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

Authors: K S Ross; H B Carter; J D Pearson; H A Guess
Journal: JAMA Date: 2000-09-20 Impact factor: 56.272

5. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Authors: J K Gohagan; P C Prorok; R B Hayes; B S Kramer
Journal: Control Clin Trials Date: 2000-12

6. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Authors: B F Hankey; E J Feuer; L X Clegg; R B Hayes; J M Legler; P C Prorok; L A Ries; R M Merrill; R S Kaplan
Journal: J Natl Cancer Inst Date: 1999-06-16 Impact factor: 13.506

7. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.

Authors: R Etzioni; J M Legler; E J Feuer; R M Merrill; K A Cronin; B F Hankey
Journal: J Natl Cancer Inst Date: 1999-06-16 Impact factor: 13.506

8. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

Authors: Harry J de Koning; Anssi Auvinen; Antonio Berenguer Sanchez; Fernando Calais da Silva; Stefano Ciatto; Louis Denis; John K Gohagan; Matti Hakama; Jonas Hugosson; Ries Kranse; Vera Nelen; Philip C Prorok; Fritz H Schröder
Journal: Int J Cancer Date: 2002-01-10 Impact factor: 7.396

9. PSA screening and prostate cancer mortality.

Authors: Linda Perron; Lynne Moore; Isabelle Bairati; Paul-Marie Bernard; François Meyer
Journal: CMAJ Date: 2002-03-05 Impact factor: 8.262

10. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Authors: Ruth Etzioni; David F Penson; Julie M Legler; Dante di Tommaso; Rob Boer; Peter H Gann; Eric J Feuer
Journal: J Natl Cancer Inst Date: 2002-07-03 Impact factor: 13.506